Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Raccah, Denis
Haak, Thomas
Huet, Dominique
Monnier, Louis
Penfornis, Alfred
Robertson, Douglas
Labard, Pascale
Soler Ramon, Juan
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A151 / A151
页数：1
相关论文
共 50 条
  • [41] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [42] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Riccardo Candido
    Kathleen Wyne
    Ester Romoli
    Diabetes Therapy, 2018, 9 : 927 - 949
  • [43] The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
    Ozturkmen, Yuksel Asli
    Avci, Suna
    Calim, Aslihan
    Cetin, Elif Guven
    Demir, Nazan
    Mazi, Emrah Erkan
    Borlu, Fatih
    Altuntas, Yuksel
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 416 - 423
  • [44] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    DIABETES THERAPY, 2018, 9 (03) : 927 - 949
  • [45] WHEN AND HOW TO USE PRANDIAL INSULIN WITH ULTRALONG-ACTING BASAL INSULIN IN T2DM
    Umpierrez, Guillermo E.
    ENDOCRINE PRACTICE, 2016, 22 : 12 - 14
  • [46] Comparison of canagliflozin and liraglutide as a replacement for bolus insulin in type 2 diabetes patients well-controlled by basal-bolus insulin
    Kumashiro, N.
    Ando, Y.
    Shigiyama, F.
    Igarashi, H.
    Yoshikawa, F.
    Uchino, H.
    Yoshino, H.
    Miyagi, M.
    Ikehara, K.
    Hirose, T.
    DIABETOLOGIA, 2018, 61 : S126 - S126
  • [47] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY VERSUS BASAL-BOLUS FULL REGIMEN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ALGERIA
    Sellam, Y.
    Malek, R.
    Semrouni, M.
    Belhadj, M.
    Zekri, S.
    Brouri, M.
    Arbouche, Z.
    Nouri, N.
    VALUE IN HEALTH, 2020, 23 : S511 - S511
  • [48] Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Gron, Randi
    Halladin, Natalie
    Jodar, Esteban
    DIABETES CARE, 2018, 41 (05) : 1009 - 1016
  • [49] A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
    Sultan Linjawi
    Byung-Wan Lee
    Ömür Tabak
    Susanna Lövdahl
    Shanti Werther
    Salahedeen Abusnana
    Diabetes Therapy, 2018, 9 : 1 - 11
  • [50] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    Kate van Brunt
    Bradley Curtis
    Tibor Ivanyi
    Elemer Balogh
    Corina Chalkiadaki
    Sharon MacLachlan
    David Neasham
    Mireia Raluy-Callado
    Diabetes Therapy, 2016, 7 : 793 - 807
12345